scispace - formally typeset
C

Ciro Casanova Macario

Researcher at University of La Laguna

Publications -  25
Citations -  252

Ciro Casanova Macario is an academic researcher from University of La Laguna. The author has contributed to research in topics: COPD & Medicine. The author has an hindex of 7, co-authored 22 publications receiving 215 citations. Previous affiliations of Ciro Casanova Macario include Tufts University.

Papers
More filters
Journal ArticleDOI

Comparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease Reports. Impact on Grouping and Outcomes

TL;DR: Compared with 2015, the GOLD ABCD 2017 classification significantly shifts patients from grades C and D to categories A and B, making the risk of death similar between them, and the mortality risk was better predicted by the 2015 than the 2017 system.
Journal ArticleDOI

Time to desaturation in the 6-min walking distance test predicts 24-hour oximetry in COPD patients with a PO2 between 60 and 70mmHg

TL;DR: The time to desaturation in the 6MWD test can discriminate early desaturators who desaturate during their daily living activities and late desaturator who do not desaturates.
Journal ArticleDOI

Patología respiratoria y vuelos en avión

TL;DR: A lo largo of las últimas décadas, se ha experimentado un incremento progresivo del número de personas that utilizan aviones para sus desplazamientos, y los síntomas respiratorios son causantes de buena parte of las emergencias que se producen a bordo of un avión.
Journal ArticleDOI

Air Travel and Respiratory Disease

TL;DR: Although adverse respiratory events as a result of air travel are not common, this form of transport does present potential risks and there are problems in the assessment of patients prior to the flight or in their in-flight care, suggesting the importance of careful assessment prior to flight.
Journal ArticleDOI

Prognostic assessment of patients with COPD.

TL;DR: From the evidence, ADO and BODE do predict mortality but BODE is better than ADO for categorising COPD severity and changes in indices such as BODE cannot be used as surrogate markers of outcome.